Available from: Zhang L, Qiu L, Xu S, Cheng X, Wu J, Wang Y, et al
It is important to note that while GLP-1RAs have demonstrated CV safety, not all result in an actual reduction in CV adverse events, such as exenatide QW and lixisenatide, both of which were reported to be non-inferior to placebo for MACE [22, 23]
In the context of sepsis, while results on overall mortality have been mixed across studies, IV vitamin C has demonstrated an ability to significantly improve Sequential Organ Failure Assessment (SOFA) scores, indicating improved organ function
Safety and efficacy of L-carnitine supplementation in improving cardiac function of hemodialysis patients: a systematic review and meta-analysis